Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
The Global Continuous Renal Replacement Therapy (CRRT) Market was valued at USD 0.88 billion in 2016 and is projected to reach USD 1.60 billion by 2025, growing at a CAGR of 6.85% from 2017 to 2025.
Acute Renal Therapy includes multiple therapy types, including the two most common; continuous renal replacement therapy (CRRT) and Therapeutic Plasma Exchange (TPE). CRRT is a dialysis modality used to treat critically ill, hospitalized patients in the intensive care unit who develop acute kidney injury (AKI).
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Increasing Incidences of AKI
1.2 GrowingNumber of critical ICU cases
1.3 Clinical advantages of CRRT
1.4 Technological Advancements
1.5 Sepsis cases are more frequent
1.6 Growth in number of patients of diabetes and hypertension
2. Market Restraints
2.1 High Implementation cost
2.2 North America regulations suppressing the usage of CRRT
Market Segmentation:
1. Global Continuous Renal Replacement Therapy (CRRT) Market, by Product:
1.1 Dialysates and Replacement Fluids
1.2 Disposables
1.2.1 Eucalyptus
1.2.2 Citronella
1.2.3 Peppermint
1.3 Hemofilters
1.4 Bloodline Sets (Tubing Sets)
1.5 Other Disposables
2. Adoption of Continuous Renal Replacement Therapy (CRRT), by Region:
2.1 Utilization of CRRT Procedures, By Region
2.2 Number of CRRT Patients, By Region
3. Global Continuous Renal Replacement Therapy (CRRT) Market, by Region:
3.1 North America (U.S., Canada, Mexico)
3.2 Europe (Germany, UK, France, Rest of Europe)
3.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
3.4 Latin America (Brazil, Argentina, Rest of Latin America)
3.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Baxter International Inc.
2. Fresenius Medical Care AG & Co. KGaA
3. Nikkiso Co., Ltd.
4. Nxstage Medical, Inc.
5. B. Braun Melsungen AG
6. Asahi Kasei Medical Co., Ltd. (A Subsidiary of Asahi Kasei Corporation)
7. BeLLCo S.R.L. (A Part of Medtronic PLC)
8. Toray Medical Co., Ltd.
9. Infomed SA
10. Medica S.P.A.
11. Medical Components, Inc.
12. Medites Pharma Spol. S.R.O.
13. Medtronic PLC
14. SWS Hemodialysis Care Co. Ltd.
15. Ningbo Tianyi Medical Appliance Co., Ltd.
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Continuous Renal Replacement Therapy (CRRT) Marketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.